Smart artificial beta cells could lead to new diabetes treatment
Researchers have designed synthetic beta cells that secrete insulin in response to high blood sugar...
List view / Grid view
News
FDA approves new dosing for Xarelto to reduce the risk of VTE
The FDA has approved the 10 mg once-daily dose of Xarelto, for reducing the continued risk of recurrent venous thromboembolism...
New treatments help those with mild, moderate and severe eczema
Crisaborole and dupilumab approved for atopic dermatitis…
New initiative to accelerate development of universal influenza vaccines
Universal Influenza Vaccine Initiative will address the underlying scientific barrier impeding the development of broadly protective, universal influenza vaccines...
Sandoz proposed biosimilar pegfilgrastim accepted by EMA
Sandoz has announced that its biosimilar pegfilgrastim has been accepted by the EMA for regulatory review...
Researchers identify ineffectiveness of Alzheimer’s drug semagacestat
Scientists have found that some potential γ-secretase inhibitors such as semagacestat, do not function as true inhibitors as originally expected...
FDA collaboration uses Organs-on-Chips to improve drug development
FDA collaboration will characterise the performance of Organs-on-Chips as a platform for potential use in drug development and regulatory evaluation...
Tarloxitinib puts tumour-seeking tail on anti-EGFR drug to target lung cancer
Researchers have proposed a unique way to reach the concentration of anti-EGFR drug needed to fight exon 20 insertions without harming healthy tissues...
17th Annual Strategic Project & Portfolio Management for Pharma
With ongoing and ever tightened budget cuts, pharma companies are struggling to prioritise projects with limited R&D budget – whilst at the same time the patent cliff is drying up the product pipeline which will have immense aftermaths of the company’s revenue stream...
Anticoagulant drugs appear to reduce the risk of stroke in patients with AF
Blood-thinning drugs not only reduce the risk of stroke in patients with AF but are also associated with a significant reduction in the risk of dementia...
Proton therapy may be better option for patients with esophageal cancer
Proton beam therapy, in combination with chemotherapy, may be a better treatment option than traditional radiation therapy techniques...
Blood-based epigenetic may hold clues to autism
Epigenetic data reveals immune-response pathways that may prove critical to understanding autism...
Albendazole-antibiotic combination shortens therapy for parasitic diseases
Researchers have found a way of reducing the treatment required for lymphatic filariasis and onchocerciasis from several weeks to seven days...
Statin use linked to heightened type 2 diabetes risk in susceptible individuals
Experimental research suggests that statins may impair the production of insulin...
FDA approves Bydureon BCise for patients with type-2 diabetes
The FDA has approved Bydureon BCise for adults with type-2 diabetes whose blood sugar remains uncontrolled on one or more oral medicines...
